A prospective study of noninvasive pulmonary hydrometry for optimizing the management of patients with heart failure

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400091870

Enrollment

Unknown

Registered

2024-11-05

Start date

2024-11-10

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute decompensated heart failure

Interventions

Gold Standard:Clinical outcome

Index test: noninvasive pulmonometer index (lung fluid content)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Aged 18 years or older (2) Patients hospitalized for acute decompensated heart failure in the Department of Cardiology, West China Hospital, Sichuan University

Exclusion criteria

Exclusion criteria: (1) Complicated with severe lung disease (previous diagnosis of pulmonary fibrosis, emphysema, COPD) (2) Pregnant; (3) Assessing physical conditions unsuitable for wearing the ReDS™ non-invasive pulmonometer, including but not limited to: BMI39kg/m2, or height 195cm, or flail chest, etc. (ReDS™ test is required for patients with a BMI of 20-22kg/m2, and for patients with a height of 150-155cm to ensure physical fitness); (4) Malignant tumor; (5) Reluctance to participate; (6) Doctors consider him/her inappropriate to participate in this study.

Design outcomes

Primary

Measure	Time frame
Lung fluid content;Lung B line;	—

Secondary

Measure	Time frame
N-terminal pro-brain natriuretic peptide(NT-proBNP);	—

Countries

China

Contacts

Public ContactQing Zhang

West China Hospital, Sichuan University

qzhang2000cn@163.com+86 189 8060 1267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026